Comment
doi: 10.1016/S0140-6736(15)60686-9.
Epub 2015 Jul 9.
Doxorubicin in stage II-III, intermediate-risk Wilms' tumour
Affiliations
- PMID: 26164099
- DOI: 10.1016/S0140-6736(15)60686-9
Item in Clipboard
Comment
Doxorubicin in stage II-III, intermediate-risk Wilms' tumour
Lancet.
.
Free article
No abstract available
Comment on
-
Omission of doxorubicin from the treatment of stage II-III, intermediate-risk Wilms' tumour (SIOP WT 2001): an open-label, non-inferiority, randomised controlled trial.Lancet. 2015 Sep 19;386(9999):1156-64. doi: 10.1016/S0140-6736(14)62395-3. Epub 2015 Jul 9. Lancet. 2015. PMID: 26164096 Clinical Trial.
Similar articles
-
Paediatrics: Doxorubicin is not necessary in postoperative chemotherapy for Wilms tumour.Nat Rev Urol. 2015 Sep;12(9):473. doi: 10.1038/nrurol.2015.186. Epub 2015 Jul 28. Nat Rev Urol. 2015. PMID: 26215689 No abstract available.
-
Treatment of Wilms' tumour. Current recommendations.Drugs. 1991 Nov;42(5):766-80. doi: 10.2165/00003495-199142050-00004. Drugs. 1991. PMID: 1723373 Review.
-
Relationship between dose schedule and charges for treatment on National Wilms' Tumor Study-4. A report from the National Wilms' Tumor Study Group.J Natl Cancer Inst Monogr. 1995;(19):21-5. J Natl Cancer Inst Monogr. 1995. PMID: 7577200 Clinical Trial.
-
Treatment of children with stages II to IV anaplastic Wilms' tumor: a report from the National Wilms' Tumor Study Group.J Clin Oncol. 1994 Oct;12(10):2126-31. doi: 10.1200/JCO.1994.12.10.2126. J Clin Oncol. 1994. PMID: 7931483 Clinical Trial.
-
[Chemotherapy of nephroblastoma].Urol Nefrol (Mosk). 1984 May-Jun;(3):68-70. Urol Nefrol (Mosk). 1984. PMID: 6330952 Review. Russian. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
